Tarka and atrial fibrillation Patient Reports February 13, 2012

Tarka Side Effects Report #5651684-1
Tarka side effect was reported by a Consumer or non-health professional from POLAND on Feb 29, 2008. Female patient, 79 years of age, weighting 165.3 lb, was diagnosed with hypertension and was treated with Tarka. After drug was administered, patient experienced the following side effects: atrial fibrillation . Tarka dosage: 180MG/2MG. During the same period patient was treated with SPIRONOLACTONE, PROPAFENONE HYDROCHLORIDE, STATINS, ACENOCOUMAROL, PANCREATIN TRIPLE STRENGTH CAP, SILYBUM MARIANUM. Patient was hospitalized. Patient recovered.

Tarka Side Effects Report #5713589-7
Tarka side effect was reported by a Consumer or non-health professional from POLAND on Apr 14, 2008. Female patient, 79 years of age, weighting 165.3 lb, was diagnosed with hypertension and was treated with Tarka. After drug was administered, patient experienced the following side effects: atrial fibrillation . Tarka dosage: 180MG/2MG DAILY, ORAL. During the same period patient was treated with STATINS, ACENOCOUMAROL, PANCREATIN TRIPLE STRENGTH CAP, SILYBUM MARIANUM. Patient was hospitalized. Patient recovered.

Tarka Side Effects Report #4937330-0
Tarka side effect was reported by a Physician from GREECE on Mar 01, 2006. Female patient, 46 years of age, weighting 194.0 lb, was diagnosed with hypertension, atrial fibrillation  and was treated with Tarka. After drug was administered, patient experienced the following side effects: atrial fibrillation , bradycardia. Tarka dosage: unknown. During the same period patient was treated with PROPAFENONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, ACENOCOUMAROL. Patient was hospitalized. Patient recovered.

Tarka Side Effects Report #4965953-1
Tarka side effect was reported by a Consumer or non-health professional from PUERTO RICO on Aug 18, 2005. Male patient, weighting 215.2 lb, was diagnosed with hypertension, blood potassium decreased, anxiety , tooth extraction, prophylaxis, dyslipidaemia, diabetes mellitus non-insulin-dependent and was treated with Tarka. After drug was administered, patient experienced the following side effects: acidosis, anaemia, atrial fibrillation , coagulopathy, diaphragmatic paralysis, gastrointestinal haemorrhage, hyperglycaemic hyperosmolar nonketotic syndrome, international normalised ratio increased, pleural effusion. Tarka dosage: unknown. During the same period patient was treated with BUMETANIDE, POTASSIUM, ALPRAZOLAM, BENZYLPENICILLIN, ACETYLSALICYLIC ACID SRT, RAMIPRIL, CRESTOR, METFORMIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.